Search

393884
209802
205763
1149212
212716
Community Engagement
On Saturday 28 March 2015 the South African Tuberculosis Vaccine Initiative (SATVI) marked World TB Day with a Wellness Expo at the Zwelethemba Sport Stadium in Worcester. The program for the day included a 3 Km Fun Run, a Kick TB Soccer Tournament...
Accredited UCT Research Centre
The South African Tuberculosis Vaccine Initiative (SATVI) is an accreditated Research Centre of the University of Cape Town.
South African Tuberculosis Vaccine Initiative
SATVI is a tuberculosis research group accommodating several disciplines including paediatrics, infectious diseases, epidemiology, public health, immunology and clinical/biological sciences. SATVI has a large and well-developed clinical field site...
Join us at the 46th Union World Conference on Lung Health 2-6 December 2015
South African Tuberculosis Vaccine Initiative has announced its participation in 46th Union World Conference on Lung Health.
Welcome to the South African Tuberculosis Vaccine Initiative
SATVI is regarded as a leader in tuberculosis vaccine clinical research worldwide and is the largest dedicated tuberculosis vaccine research group on the African continent. Our laboratories are accredited, which means adherence to the highest...

News

Saturday, 6 February 2016

Associate Professor Thomas Scriba has co-authored a research paper titled "Individual-level factors associated with variation in mycobacterial-specific immune response: Gender and previous BCG vaccination status."

Publication Date:
Tuesday, February 2, 2016 - 10:00

Associate Professor Mark Hatherill, has co-authored a paper titled: "First-in-human trial of a live-attenuated Mycobacterium tuberculosis vaccine" appearing in the December issue of the Lancet Respiratory Medicine.

Publication Date:
Monday, January 18, 2016 - 13:45

On Thursday 17 December SATVI Director Mark Hatherill, spoke to Azania Mosaka from Radio 702 and Cape Talk about the work that SATVI is doing to develop a biomarker test to predict whether a person is at risk of developing full-blown TB. Listen to the interview online.

Publication Date:
Friday, December 18, 2015 - 17:30

Researchers from SATVI have participated in a study resulting in the publication of a paper titled  "A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents".

Publication Date:
Wednesday, December 9, 2015 - 19:30

Pages